Abstract
A commercial latex agglutination (LA) test for the detection of circulatingAspergillus galactomannan was evaluated in sera obtained from 121 immunocompromised patients, including 19 with proven invasive pulmonary aspergillosis. Patient urine (the specimen of choice for detection of galactomannan) was not tested with the LA test as 34 of 81 specimens from controls gave false-positive results. The sensitivity (95 %), specificity (90 %) and negative predictive value (99 %) of the LA test were similar to previously published results obtained with two EIAs. However, the positive predictive value was only 67 % compared to ≥95 % obtained with the EIAs. In addition, the LA test was also of less value than the EIAs in predicting the onset of invasive pulmonary aspergillosis. It was the earliest indicator of infection in only 1 of 19 proven cases.
Similar content being viewed by others
References
Walsh TJ, Lee JW, Roilides E, Pizzo PA Recent progress and current problems in management of invasive fungal infections in patients with neoplastic diseases. Current Opinion in Oncology 1992, 4: 647–655.
Spearing RL, Pamphilon DH, Prentice AG Pulmonary aspergillosis in immunosuppressed patients with haematological malignancies. Quarterly Journal of Medicine 1986, 59: 611–625.
Young RC, Bennett JE Invasive aspergillosis: absence of detectable antibody response. American Review of Respiratory Disease 1971, 104: 710–716.
Johnson TM, Kurup VP, Resnick A, Ash RC, Fink JN, Kalbfleisch J Detection of circulatingAspergillus fumigatus antigen in bone marrow transplant patients. Journal of Laboratory and Clinical Medicine 1989, 114: 700–707.
Rogers TR, Haynes KA, Barnes RA Value ofAspergillus antigen detection in predicting invasive aspergillosis. Lancet 1990, 336: 1210–1213.
Wilson EV, Hearn VM, Mackenzie DWR Evaluation of a test to detect circulatingAspergillus fumigatus antigen in a survey of immunocompromised patients with proven or suspected invasive disease. Journal of Medical and Veterinary Mycology 1987, 25: 365–374.
Bardalaye PC, Nordin JH Chemical structure of the galactomannan from the cell wall ofAspergillus niger. Journal of Biological Chemistry 1977, 252: 2584–2591.
Debeaupuis JP, Sarfati J, Goris A, Stynen D, Diaquin M, Latge JP Exocellular polysaccharides fromAspergillus fumigatus and related taxa. In: Samson RA, Pitt JI (ed): Modern concepts inPenicillium andAspergillus classification. Plenum Publishing, London, 1989, p. 209–223.
van Cutsem J, Meulemans L, van Gerven F, Stynen D Detection of circulating galactomannan by Pastorex Aspergillus in experimental invasive aspergillosis. Mycoses 1990, 33: 61–69.
Dupont B, Huber M, Kim SJ, Bennett JE Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. Journal of Infectious Diseases 1987, 155: 1–11.
Dupont B, Improvisi L, Prevot F Detection de galactomannane dans les aspergilloses invasives humaines avec un test au latex. Bulletin de Societe Francais de Mycologie Medicale 1990, 19: 35–41.
Reiss E, Lehmann PF Galactomannan antigenemia in invasive aspergillosis. Infection and Immunity 1979, 25: 357–365.
de Repentigny L, Boushira M, Ste-Marie L, Bosisio G Detection of galactomannan antigenemia by enzyme immunoassay in experimental invasive aspergillosis. Journal of Clinical Microbiology 1987, 25: 863–867.
Warnock DW, Foot AB, Johnson EM, Mitchell SB, Cornish JM, Oakhill A Aspergillus antigen latex test for diagnosis of invasive aspergillosis. Lancet 1991, 338: 1023–1024.
Bennett JE, Friedman MM, Dupont B Receptor mediated clearance ofAspergillus galactomannan. Journal of Infectious Diseases 1987, 155: 1005–1010.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haynes, K., Rogers, T.R. Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients. Eur. J. Clin. Microbiol. Infect. Dis. 13, 670–674 (1994). https://doi.org/10.1007/BF01973998
Issue Date:
DOI: https://doi.org/10.1007/BF01973998